Saturna Capital’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-12,540
| Closed | -$82.1K | – | 175 |
|
|
2023
Q3 | $82.1K | Hold |
12,540
| – | – | ﹤0.01% | 173 |
|
|
2023
Q2 | $102K | Sell |
12,540
-5,410
| -30% | -$44K | ﹤0.01% | 164 |
|
|
2023
Q1 | $154K | Buy |
17,950
+5,650
| +46% | +$48.4K | ﹤0.01% | 156 |
|
|
2022
Q4 | $114K | Hold |
12,300
| – | – | ﹤0.01% | 149 |
|
|
2022
Q3 | $127K | Hold |
12,300
| – | – | ﹤0.01% | 154 |
|
|
2022
Q2 | $123K | Hold |
12,300
| – | – | ﹤0.01% | 158 |
|
|
2022
Q1 | $151K | Sell |
12,300
-1,500
| -11% | -$18.4K | ﹤0.01% | 167 |
|
|
2021
Q4 | $239K | Buy |
13,800
+200
| +1% | +$3.46K | ﹤0.01% | 159 |
|
|
2021
Q3 | $244K | Buy |
13,600
+500
| +4% | +$8.97K | ﹤0.01% | 161 |
|
|
2021
Q2 | $299K | Hold |
13,100
| – | – | 0.01% | 153 |
|
|
2021
Q1 | $196K | Buy |
+13,100
| New | +$196K | ﹤0.01% | 162 |
|